Ireland HPRA

Mykronor Noradrenaline 5 μg/mL Medication Error DHPC

HPRA Ireland published a Direct Healthcare Professional Communication (DHPC) from Laboratoire Aguettant regarding Mykronor (Noradrenaline) 5 μg/mL solution for injection/infusion. The DHPC addresses a potential risk of medication errors associated with this product. Healthcare professionals who prescribe, dispense, or administer this noradrenaline formulation should review the communication for specific risk mitigation guidance.

Omnipaque Visipaque 100ml Batch Recall Particles

HPRA Ireland has issued a user-level batch recall for specific lots of Omnipaque 350 mg I/ml Solution for Injection and Visipaque 320 mg I/ml Solution for Injection due to potential particle contamination in 100ml polypropylene bottles. Affected batches are Omnipaque lot 17413362 (expiry 15.10.2028) and Visipaque lot 17230467 (expiry 14.08.2028), both authorised to GE Healthcare AS. Glass bottle presentations are not affected. Pharmacists must quarantine stock, complete the recall form, and notify relevant healthcare facilities.

Drug Safety Newsletter Issue 122: Hydroxycarbamide CGM Interference and Miconazole-Warfarin Interaction

The HPRA Drug Safety Newsletter Issue 122 (April 2026) covers four safety topics for medicines for human use: potential interference of hydroxycarbamide-containing products with continuous glucose monitoring systems; a drug-drug interaction between topical miconazole and warfarin; the importance of reporting suspected adverse reactions to pharmacovigilance; and updates from EMA's PRAC. The newsletter also references Direct Healthcare Professional Communications published on the HPRA website since the prior issue.